Literature DB >> 26656711

Comparative Mutagenesis of Pseudorabies Virus and Epstein-Barr Virus gH Identifies a Structural Determinant within Domain III of gH Required for Surface Expression and Entry Function.

Britta S Möhl1, Christina Schröter2, Barbara G Klupp2, Walter Fuchs2, Thomas C Mettenleiter2, Theodore S Jardetzky3, Richard Longnecker4.   

Abstract

UNLABELLED: Herpesviruses infect cells using the conserved core fusion machinery composed of glycoprotein B (gB) and gH/gL. The gH/gL complex plays an essential but still poorly characterized role in membrane fusion and cell tropism. Our previous studies demonstrated that the conserved disulfide bond (DB) C278/C335 in domain II (D-II) of Epstein-Barr virus (EBV) gH has an epithelial cell-specific function, whereas the interface of D-II/D-III is involved in formation of the B cell entry complex by binding to gp42. To extend these studies, we compared gH of the alphaherpesvirus pseudorabies virus (PrV) with gH of the gammaherpesvirus EBV to identify functionally equivalent regions critical for gH function during entry. We identified several conserved amino acids surrounding the conserved DB that connects three central helices of D-III of PrV and EBV gH. The present study verified that the conserved DB and several contacting amino acids in D-III modulate cell surface expression and thereby contribute to gH function. In line with this finding, we found that DB C404/C439 and T401 are important for cell-to-cell spread and efficient entry of PrV. This parallel comparison between PrV and EBV gH function brings new insights into how gH structure impacts fusion function during herpesvirus entry. IMPORTANCE: The alphaherpesvirus PrV is known for its neuroinvasion, whereas the gammaherpesvirus EBV is associated with cancer of epithelial and B cell origin. Despite low amino acid conservation, PrV gH and EBV gH show strikingly similar structures. Interestingly, both PrV gH and EBV gH contain a structural motif composed of a DB and supporting amino acids which is highly conserved within the Herpesviridae. Our study verified that PrV gH uses a minimal motif with the DB as the core, whereas the DB of EBV gH forms extensive connections through hydrogen bonds to surrounding amino acids, ensuring the cell surface expression of gH/gL. Our study verifies that the comparative analysis of distantly related herpesviruses, such as PrV and EBV, allows the identification of common gH functions. In addition, we provide an understanding of how functional domains can evolve over time, resulting in subtle differences in domain structure and function.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26656711      PMCID: PMC4810733          DOI: 10.1128/JVI.03032-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Structure-based functional analyses of domains II and III of pseudorabies virus glycoprotein H.

Authors:  Sebastian W Böhm; Elisa Eckroth; Marija Backovic; Barbara G Klupp; Felix A Rey; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Analysis of fusion using a virus-free cell fusion assay.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Methods Mol Biol       Date:  2005

3.  The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells.

Authors:  Q Li; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells.

Authors:  T Ben-Porat; J DeMarchi; J Pendrys; R A Veach; A S Kaplan
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

5.  Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus.

Authors:  B Lomniczi; S Watanabe; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

6.  Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame.

Authors:  D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  The highly conserved proline at position 438 in pseudorabies virus gH is important for regulation of membrane fusion.

Authors:  Christina Schröter; Barbara G Klupp; Walter Fuchs; Marika Gerhard; Marija Backovic; Felix A Rey; Thomas C Mettenleiter
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

8.  Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism.

Authors:  Momei Zhou; Jean-Marc Lanchy; Brent J Ryckman
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

9.  A Viral Pilot for HCMV Navigation?

Authors:  Barbara Adler
Journal:  Viruses       Date:  2015-07-15       Impact factor: 5.048

10.  Assembly and architecture of the EBV B cell entry triggering complex.

Authors:  Karthik Sathiyamoorthy; Jiansen Jiang; Yao Xiong Hu; Cynthia L Rowe; Britta S Möhl; Jia Chen; Wei Jiang; Elizabeth D Mellins; Richard Longnecker; Z Hong Zhou; Theodore S Jardetzky
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

View more
  2 in total

1.  Pseudorabies virus infection inhibits autophagy in permissive cells in vitro.

Authors:  Mingxia Sun; Linlin Hou; Yan-Dong Tang; Yonggang Liu; Shujie Wang; Jingfei Wang; Nan Shen; Tongqing An; Zhijun Tian; Xuehui Cai
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

Review 2.  Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.

Authors:  Britta S Möhl; Jia Chen; Karthik Sathiyamoorthy; Theodore S Jardetzky; Richard Longnecker
Journal:  Mol Cells       Date:  2016-04-06       Impact factor: 5.034

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.